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Objectives: to examine the factors influencing outcome and restenosis in an initial series of 100 infrainguinal angioplasties.
Design: prospective study of angioplasties of the superficial femoral and popliteal arteries performed over a 42-month
period.
Materials and methods: one hundred consecutive angioplasties in 96 patients performed in the operating theatre
between January 1993 and June 1996 were followed prospectively with clinical, ABI, and duplex assessment. Forty-four
procedures were for disabling claudication and 56 for critical ischaemia. Stents were deployed in 30 limbs.
Results: angioplasty was successful in 84 of 100 limbs. Cumulative patency of the entire group at 3, 6, 12 and 18
months was 78%, 60%, 53%, and 49% respectively, while excluding initial failures, gave patencies of 95%, 69%, 63%,
and 58%, respectively. Claudicants with a 1-year patency of 64% did significantly better than patients with critical
ischaemia (44% p<0.05). Angioplasties performed during the initial 21 months had a 1-year patency of 42%, while those
performed in the final 21 months had a 74% patency (p=N.S.). The patency for stented arteries was 66% vs. 49% for
angioplasty alone (p=N.S.). The 2-year limb salvage rate was 91% in patents with critical ischaemia. Forty-six per cent
of restenoses were asymptomatic.
Conclusions: the results suggest that while angioplasty is useful in treating infrainguinal arterial disease, there is a
learning curve, resulting in a high restenosis rate for occlusive and multilevel disease, while concomitant placement of
stents may be beneficial.
Key Words: Femoropopliteal; Angioplasty; Stenting.
Introduction PTA. The results of angioplasty performed in con-
junction with the use of stents as primary procedures
Percutaneous transluminal angioplasty (PTA) has be- or for technically imperfect angioplasties have been
encouraging.9,10 In addition, the increasing in-come an accepted technique in the management of
critical limb ischaemia, although its role in the man- volvement of vascular surgeons in PTA, stenting and
endovascular grafting adds a heretofore unexploredagement of intermittent claudication remains con-
troversial.1–3 While the long-term results of PTA in the dimension to these techniques.11
The aim of this study was to examine the results ofiliac system are excellent, there has been dis-
appointment with the results in the femoropopliteal endovascular treatment of our first 100 patients with
femoropopliteal disease and to determine factors af-area. The 5-year restenosis rate for PTA has been
reported as ranging from 30–60% in cases of both fecting outcome and restenosis.
claudication and critical ischaemia, but the primary
success in patients with total occlusions having con-
ventional PTA remains poor.4,5
Patients and MethodsMany techniques have been tried to overcome these
problems including laser and various atherectomy
All peripheral angioplasties performed at St. James’sdevices with equally poor results.6–8 More recently,
Hospital since January 1993 have been followed pro-several endoprostheses or stents as well as intraluminal
spectively. Between January 1993 and June 1996 100grafts have been developed as adjuncts to conventional
primary endovascular procedures have been per-
formed on the superficial femoral and popliteal arteries
* Please address all correspondence to: M. K. O’Donohoe, Depart- of 96 patients. The mean age was 69 (range 46–87) andment of Surgery, Adelaide and Meath Hospital, Tallaght, Dublin 24,
Ireland. the male:female ratio 1.3:1. The risk factors for vascular
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disease included diabetes (31), ischaemic heart disease were obtained following a single inflation of a balloon
which completely crossed the lesion than following(52) hypertension (33) and a history of tobacco use
(75). several inflations of a shorter balloon. Two kinds of
stent were deployed. Palmaz stents (Johnson and John-Fifty-six procedures were for critical ischaemia
either rest pain (21), lasting a minimum of 2 weeks, son Interventional Systems, Warren, New Jersey,
U.S.A.) 4–9 mm diameter and 10–39 mm long wereulceration (19) or gangrene (16). Forty-four procedures
were for disabling claudication. Specific preoperative used in the initial part of the study in 23 patients, a
single stent in 18 and two stents in five. A singleinvestigations included clinical examination, non-in-
vasive assessment, and digital subtraction angio- Memotherm nitinol stent (Angiomed GmbH, Karls-
ruhe, Germany, division of Bard) 6–8 mm diametergraphy. Non-invasive assessment included full
segmental and toe pressures as well as duplex scanning and 60–120 mm long was deployed in the latter period
in seven patients. The criteria for stent deploymentof the femoropopliteal segment and marking of the
lesions prior to surgery. were technically imperfect results following PTA:
either a residual stenosis of >30% or severe angioplasty
induced dissection which impinged significantly on
the true lumen in all cases. However, the availability
Endovascular technique of the longer flexible Memotherm stent in the latter
part of the study resulted in their deployment in most
All procedures were performed in the operating cases of occlusion or multiple stenoses in order to
theatre using C-arm image intensification with full stent the entire segment of the artery which required
digital subtraction and road mapping facilities (Sie- angioplasty. The type and length of lesion i.e. stenosis,
mens Siremobil 2000, Erlangen, Germany). Spinal or occlusion, multilevel disease were noted at the time of
epidural anaesthesia was employed in 80 cases while surgery and measured using the intraluminal balloon
17 had general anaesthesia and three local. In all cases catheter as measuring scale.
an anaesthetist was present. All patients were prepared
and draped as for open bypass surgery. Patients re-
ceived 300 mg of aspirin on the day prior to surgery
and daily thereafter and received heparin 75 IU/kg Follow-up
intraoperatively which was not reversed, as well as
1.2 g of co-amoxiclav I.V. (Augmentin, SmithKline Patients without complicating ulceration or gangrene
were usually discharged on the first postoperative dayBeecham).
A percutaneous Seldinger approach was attempted, following duplex assessment and were followed up at
6 weeks, 3 months, 6 months, and 6-monthly thereafter.either ipsilateral antegrade common femoral puncture
for distal superficial femoral or popliteal lesions, or a Follow-up consisted of clinical examination, ABPI
measurement and duplex scanning. Restenosis wascontralateral retrograde ‘‘over the top’’ approach for
proximal superficial femoral lesions. Open exposure defined as a return of symptoms, a diminution in
pulses or a 0.15 fall in ABPI or in the absence of anyof the ipsilateral artery was only employed in cases
of failed puncture or where concomitant iliac and of these criteria a 2-fold increase in the peak systolic
velocity over the lesion on duplex scanning.femoral angioplasty was required and in these cases
the artery was punctured and the sheath puncture site Standard life table analysis was used to determine
patency rates and failures were defined as restenosis,repaired with interrupted 6-0 polypropyline sutures.
After puncture the arteries were cannulated with a occlusion, amputation and the need for a secondary
angioplasty or other vascular procedure. The whole6–8 Ch sheath. While standard 0.035 inch guidewires
were used in some cases, the majority required 0.035 group was initially examined on the basis of intention
to treat or successful surgery. The following variablesinch hydrophilic wires or in some cases 0.018 inch
wires. In many cases, particularly those with oc- were then assessed independently on an intention to
treat basis for factors affecting outcome: (i) indication–clusions, a 5 Ch angled Bernstein catheter was also
used. Road mapping was usually required to traverse claudication or critical ischaemia, (ii) lesion treated:
single stenosis, multiple stenoses, single occlusion,stenotic lesions and always in occlusions. All lesions
had transluminal angioplasty using balloon sizes ran- single occlusion and stenosis or multiple occlusions,
(iii) angioplasty or stent, (iv) initial or final 21 months.ging from 4–7 mm. In the initial period under review
4 cm long balloons were most commonly used but in Statistical analysis of the life-tables was by way of the
log-rank test, while categorical data were analysedthe latter period there was increasing use of 10 cm
balloons. It was found that better technical results using Fisher’s exact test.
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Table 1. Indications for surgery and lesions treated.
Stenosis Occlusion
Single Multiple Single Multiple or +
stenosis
Number 31 23 36 10
Length 2.8 6.5 5 4
(Mean/range, cm) 0.5–7 1–15 2–13 2–10
Critical ischaemia 13 14 22 7
Claudication 18 9 14 3
Table 2. Technical success and patency at 1-year for the various groups.
Technical 1-year p
success (%) patency (%)
Claudication 89 64* *p<0.05
Critical ischaemia 82 44*
Single stenosis 94 70**†
Multiple stenoses 100 61** **p<0.05
Single occlusion 75 41†
Multiple occlusion or stenosis and occlusion 72 19† †p<0.05
Angioplasty alone 80 49‡
Stent 93 66‡ ‡p=n.s.
Jan 1993–Sept 1994 84 42§
Oct 1994–June 1996 84 74§ §p=n.s.
Results
One hundred procedures were performed on 96
patients. The procedures were performed per-
cutaneously in 85 limbs and by open exposure of the
common femoral artery in 15.
The indications for surgery and the lesions treated
are shown in Table 1. A single stenosis or occlusion
was defined as a single uninterrupted lesion with the
vessel above and below appearing normal. Multiple
stenoses were defined as isolated lesions with normally
appearing vessel between them, while arteries with
multiple occlusions or single occlusions and separate
stenoses are recorded separately. Overall there was
an 84% technical success rate. This was unchanged 24
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throughout the period under study and varied from
72% for multiple occlusions to 100% for multiple sten- Fig. 1. Cumulative patency after infrainguinal angioplasty and
stenting. Numbers at risk ( ).oses (Table 2). Of the 14 immediate failures nine under-
went an immediate bypass. Six of these bypasses were
planned preoperatively in the event of failure of the Fig. 1. The patency at 1-year and 18 months for the
entire group was 53% and 49%, respectively. Whenangioplasty, while three were required as a result of
acute ischaemia following angioplasty related dis- this was analysed in terms of indication for treatment
there was a significant difference in patency ratessection.
Life-table analysis of the entire group is shown in between claudicants and those with critical ischaemia.
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Table 3. Analysis of groups treated during initial and final periods.
Jan 1993–Sept 1994 Oct 1994–June 1996 p
Claudication 21 23 0.16
Critical ischaemia 35 21 0.16
Single stenosis 13 19 0.06
Multiple stenoses 10 12 0.33
Single occlusion 27 9 0.006
Occlusion (multiple or + stenosis) 6 4 0.08
Angioplasty alone 44 26 0.06
Stent 12 18 0.06
Table 4. Analysis of groups having angioplasty alone or angioplasty and stenting.
Stent Angioplasty p
Claudication 15 29 0.76
Critical ischaemia 15 41 0.76
Single stenosis 8 23 0.8
Multiple stenoses 8 15 0.18
Single occlusion 12 24 0.44
Occlusion (multiple or + stenosis) 2 8 0.9
The 1-year patencies being 64% and 44%, respectively at some point during follow-up. Of these patients,
13 remained asymptomatic, seven required arterial(p<0.05). The 1-year patency in relation to lesions
treated ranged from 71% for single stenoses to just reconstruction and eight have had a further
angioplasty.19% for multiple occlusions or stenosis and occlusion.
There was a significant difference in patency between There was minimal procedure associated morbidity,
apart from the technical failures. There were two casessingle stenosis (71%) vs. single occlusion (41%) and
multiple occlusions or stenosis and occlusion (19%) of puncture site false aneurysm, successfully treated
by duplex compression, one groin haematoma and(p<0.05). Stented arteries had a higher patency rate
than unstented arteries (66% vs. 49% 1-year patency) one microembolous distally causing skin ischaemia to
the tip of the fourth toe.but this did not reach statistical significance (Table 2).
The most striking difference was seen when the group
was analysed for period under study. Arteries treated
during the first 21 months had a 1-year patency of Discussion
48% while those treated in the latter half of the study
had a 74% 1-year patency; however, this did not reach Endovascular techniques have become accepted in the
treatment of atherosclerotic arterial disease in manystatistical significance. These two groups were then
examined separately for factors affecting outcome. In parts of the circulatory system and in some cases have
supplanted traditional open surgery in the man-general terms more patients with critical ischaemia
and more complex lesions with a significantly greater agement of these conditions.13 The superficial femoral
and popliteal arteries were among the first treatednumber of occlusions were treated in the first part of
the study, although the differences in the other lesions with PTA. Laser, atherectomy, and more recently stent-
ing have been combined with angioplasty with mixedbetween the groups did not reach statistical sig-
nificance (Table 3). results.6–9 The patency rates for superficial femoral
artery disease treated by percutaneous transluminalIn this series initial technical success following stent-
ing was higher than that with angioplasty alone (93% angioplasty still range from 43–73% at 1-year and are
accompanied by initial high technical failure ratesvs. 80%). The 1-year patency for stented arteries was
66% and for angioplasty alone 49%. These differences, ranging from 5–33%.2,4,10,11,14 The use of stents in these
patients offers several theoretical advantages, in-however, did not reach statistical significance. The
indications for surgery and the lesions treated were cluding correction of technical defects and possibly
improvement in long-term patency.9,10similar in both the stented and unstented groups (Table
4). The available literature would suggest that clau-
dicants with short segment disease may benefit fromIn patients with critical ischaemia the 2-year limb
salvage rate was 91%. Overall, of the entire 100 limbs superficial femoral/popliteal PTA+/-stenting. Fac-
tors predicting success include: claudication vs. criticaltreated, 28 patients had a restenosis, as defined above,
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ischaemia, stenosis vs. occlusion, three vessel runoff frequently excluded technical failures from the ana-
lysis.4,17vs. single vessel. Negative influences include diabetes
and diffuse disease.2,4,15 The series reported here represented the first 100
procedures performed by surgeons in the operatingThe series reported here confirms these reports,
showing a significant difference in patency for patients theatre. The techiques used have gradually been modi-
fied with the learning curve.11,12 General or regionalwith claudication vs. critical ischaemia. Similarly,
patients with short single stenotic lesions with 1-year anaesthesia was employed in most of the cases re-
ported here and prophylactic antibiotics given to allpatencies of 70% did significantly better than those
with complex stenotic and occlusive lesions with in the event of technical failure requiring either a groin
incision or open bypass surgery. Surgery could then1-year patencies of only 19%.
The other factors shown to affect outcome in this be completed without the need for the reversal of
anticoagulation before attempting regional an-study were the use of stents and the learning curve.
Arterial stenting has been suggested as a method aesthesia. As case selection has improved and the
confidence to treat various lesions endoluminally hasof improving the initial technical success following
superficial femoral and popliteal angioplasty. Stenting increased, we have increasingly used local anaesthetic
and now use local anaesthesia and no antibiotics in allwill reduce recoil, can treat dissections and reduce
residual stenoses. In this series initial technical success cases where concomitant procedures are not required.
The effect of the learning curve on outcome wasfollowing stenting was higher than that with angio-
plasty alone (93% vs. 80%). The 1-year patency for reviewed. There was no difference in initial technical
success at 84% between the groups treated in the initialstented arteries was 66% and for angioplasty alone
49%. While difference did not reach statistical sig- or latter halves of the series, indeed the first ten cases
were also all technically successful. While there wasnificance, it may be accounted for by the small number
of stents and the relatively short follow-up. However only a significant difference between the groups in the
number of occlusions treated, there was a tendencythe patency rate for stented arteries is within the range
of those previously reported (29–81%).10,16 In these for a greater number of claudicants (52 vs. 37.5%), and
a greater number of less complex lesions e.g. singlereports the percentage of claudicants were much
higher than in this series, ranging from 76 to 93%.9,16 stenoses 43 vs. 23% treated in the latter half of the
study. Similarly, a higher proportion of arteries wereOnly 44% of the patients in this series were claudicants,
50% of those stented had critical ischaemia and 74% stented in the latter half of the study (41 vs. 21%).
However, the technical success rate for occluded ar-of stented lesions were either multiple long stenoses
or occlusions. In a series of 57 patients, 50% of whom teries at 75% was lower than the previously reported
levels of 80–90%.1,5,10 This must be attributable to bothwere claudicants, Gray et al. had 22% patency rate at
1-year, thus a 66% 1-year patency for the patients the learning curve and to case selection. As the data
was being collected prospectively and under con-reported in this study compares more than favourably
with these results.17 The type of stent deployed also tinuous audit this obviously had an effect on case
selection in the latter part of the study, as it becameappears to affect outcome, with excellent results for
Palmaz stents deployed for short lesions and less more apparent which lesions were possible to treat by
endovascular techniques.favourable results for Wallstents.9,10,16,18–21 Palmaz stents
deployed in this series (n=23 limbs) had a 1-year Despite the relatively good initial technical results
reported here, the longer-term results are dis-patency rate of 54% while the six of the seven An-
giomed stents deployed were still patent 1-year, and appointing, with only 49% of arteries still patent at 18
months. The results compare favourably with somethe seventh had a distal stenosis successfully angio-
plastied. This improved patency of these stents, reported series, but falls far short of the 77% patency
rate at 2 years reported by London et al.1 In that studycoupled with their great length (up to 12 cm) flexibility,
and small sheath requirement (7 Ch) make them ideal the patient population was similar; however, duplex
scanning was not used in follow-up and this mayendoprostheses for long superficial femoral lesions.
Gray et al. deployed 10 mm diameter Wallstents in all partly account for the high restenosis rate in this
study as many restenoses are not haemodynamicallytheir arteries, regardless of size and thus the amount
of metallic surface exposed was very much larger than significant and almost 50% of our restenoses (13/28)
were asymptomatic. This is amplified by the fact thatwhen a more precise sizing is used.17
Of patients treated with angioplasty alone 66% had the limb salvage rate for critical ischaemia in this series
at 91% does compare favourably to that of London etcomplex lesions and their 49% patency rate at 1-year
also compares favourably with previous reports which al. Thus it would appear that when looked for the
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